The ECF Sponsors New Study Assessing Ophthalmic Radiation Therapy Outcomes
March 29, 2021 - Alongside the Myrna and John Daniels Fund at the Princess Margaret Cancer Center, The Eye Cancer Foundation is proud to co-sponsor the Study of Ophthalmic Radiation Therapy Toxicity (SORTT). Through the international, multicenter study, eye cancer sites across the world will assess patient outcomes for those undergoing ophthalmic radiation therapy. The goal of the study is two-fold: to support the creation of several ophthalmic radiation side effects grading system, and to accumulate evidence about risks associated with currently used ophthalmic radiation modalities. To learn more about the study or learn how your center can participate, please visit www.sortt.net.
